These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6405823)

  • 1. [Influence of thyroliberin and its analogs with different hormonal activity on the pharmacological effects of ethanol].
    Burov IuV; Vedernikova NN; Borisova IP; Shvachkin IuP; Smirnova AP
    Biull Eksp Biol Med; 1983 May; 95(5):42-4. PubMed ID: 6405823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroendocrine effect of thyroliberin and its analogs].
    Babichev VN; Samsonova VM; Airapetiants MG; Kolomeĭtseva IA; Shvachkin IuP
    Probl Endokrinol (Mosk); 1981; 27(4):35-8. PubMed ID: 6794024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats.
    Yoneda M; Goto M; Nakamura K; Shimada T; Hiraishi H; Terano A; Haneda M
    Regul Pept; 2005 Feb; 125(1-3):119-24. PubMed ID: 15582722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic ethanol or glucose consumption alter TRH content and pyroglutamyl aminopeptidase II activity in rat limbic regions.
    de Gortari P; Cisneros M; Joseph-Bravo P
    Regul Pept; 2005 Apr; 127(1-3):141-50. PubMed ID: 15680480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRH analogs with 4-nitro- and 4-N-butyloxycarbonylamino-1-methyl-2-pyrolylcarboxylic acid in position 1. Synthesis and biological properties.
    Patalan D; Kruszyński M; Zboińska J; Kupryszewski G; Grehn L; Alexandrová M; Strbák V
    Pol J Pharmacol; 1993; 45(1):83-94. PubMed ID: 8401763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
    Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations into the mechanism of reduction of ethanol sleep by thyrotropin-releasing hormone (TRH).
    Cott JM; Breese GR; Cooper BR; Barlow S; Prange AJ
    J Pharmacol Exp Ther; 1976 Mar; 196(3):594-604. PubMed ID: 177753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute administration of alcohol modulates pyroglutamyl amino peptidase II activity and mRNA levels in rat limbic regions.
    de Gortari P; Romero F; Cisneros M; Joseph-Bravo P
    Neurochem Int; 2005 Mar; 46(4):347-56. PubMed ID: 15707699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antiproliferative effects of colon mitosis inhibitor, thyroliberin and the somatostatin analog octreotide on rat colonic mucosal epithelial cells.
    Pawlikowski M; Zerek-Melen G; Winczyk K; Stepien H; Lachowicz A; Janecka A
    Cytobios; 1993; 73(292):25-30. PubMed ID: 8500346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analogs of thyrotropin-releasing hormone in potentiating the spinal monosynaptic reflex in vitro.
    Deshpande SB; Warnick JE
    Eur J Pharmacol; 1994 Dec; 271(2-3):439-44. PubMed ID: 7705444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1.
    Kaur N; Monga V; Lu X; Gershengorn MC; Jain R
    Bioorg Med Chem; 2007 Jan; 15(1):433-43. PubMed ID: 17035026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of the antidepressive and learning-stimulating effects of thyroliberin and its analogs].
    Zakusov VV; Ostrovskaia RU; Kosoĭ MIu; Gudasheva TA; Skoldinov AP
    Biull Eksp Biol Med; 1986 Jul; 102(7):39-41. PubMed ID: 3089346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroliberin (thyrotropin releasing hormone): antagonism of halothane and hexobarbital narcosis in mice. Comparison with pentetrazol, caffeine, d-amphetamine and adrenaline.
    Kruse H; Siegemund G; Rössner M
    Arzneimittelforschung; 1982; 32(3):211-3. PubMed ID: 6805483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol-induced locomotor stimulation in rats after thyrotropin-releasing hormone.
    Breese GR; Coyle S; Towle AC; Mueller RA; McCown TJ; Frye GD
    J Pharmacol Exp Ther; 1984 Jun; 229(3):731-7. PubMed ID: 6427448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the neurotropic and hormonal activity of thyrotropin releasing hormone and its analogs].
    Samsonova VM; Babichev VN; Shvachkin IuP; Smirnova AP
    Probl Endokrinol (Mosk); 1980; 26(2):48-52. PubMed ID: 6769109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thyrotropin-releasing hormone and its metabolites, Cyclo(His-Pro) and TRH-OH, on growth hormone and prolactin synthesis in primary cultured pituitary cells of the common carp, Cyprinus carpio.
    Kagabu Y; Mishiba T; Okino T; Yanagisawa T
    Gen Comp Endocrinol; 1998 Sep; 111(3):395-403. PubMed ID: 9707485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3-Me-His(2)]-TRH combined with dopamine withdrawal rapidly and transiently increases pyroglutamyl aminopeptidase II activity in primary cultures of adenohypophyseal cells.
    Bourdais J; Romero F; Uriostegui B; Cisneros M; Joseph-Bravo P; Charli JL
    Neuropeptides; 2000 Apr; 34(2):83-8. PubMed ID: 10985924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
    Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
    Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central thyrotropin-releasing hormone increases hepatic cyclic AMP through vagal-cholinergic and prostaglandin-dependent pathways in rats.
    Yoneda M; Kono T; Watanobe H; Tamano M; Shimada T; Hiraishi H; Nakamura K
    Peptides; 2005 Sep; 26(9):1573-9. PubMed ID: 16112395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.